Sinclair Pharma is an international aesthetic dermatology company, headquartered in London.
Creating and developing brand families in different areas of facial aesthetics is key to Sinclair’s growth strategy.
We provide aesthetic dermatology solutions through collagen stimulation for facial volume loss, thread lifting for facial contouring and dermal fillers for wrinkles and lines.
The company has an established sales and marketing footprint in the UK, France, Germany, Italy and Spain, and a rapidly-growing presence in emerging markets around the world through key strategic partners. We will enter the US market in 2016 with the launch of Silhouette Instalift™.
Sinclair Pharma plc is listed on the London Stock Exchange’s AIM Market (AIM: SPH).